• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野生型和突变型p53在诱导多能干细胞中差异调控的微小RNA

Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells.

作者信息

Grespi Francesca, Landré Vivien, Molchadsky Alina, Di Daniele Nicola, Marsella Luigi Tonino, Melino Gerry, Rotter Varda

机构信息

Department of Biology, University of Padua, Padua, Italy.

Medical Research Council, Toxicology Unit, Leicester University, Hodgkin Building, Leicester, UK.

出版信息

Cell Death Dis. 2016 Dec 29;7(12):e2567. doi: 10.1038/cddis.2016.419.

DOI:10.1038/cddis.2016.419
PMID:28032868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5260988/
Abstract

The tumour suppressor p53 plays an important role in somatic cell reprogramming. While wild-type p53 reduces reprogramming efficiency, mutant p53 exerts a gain of function activity that leads to increased reprogramming efficiency. Furthermore, induced pluripotent stem cells expressing mutant p53 lose their pluripotency in vivo and form malignant tumours when injected in mice. It is therefore of great interest to identify targets of p53 (wild type and mutant) that are responsible for this phenotype during reprogramming, as these could be exploited for therapeutic use, that is, formation of induced pluripotent stem cells with high reprogramming efficiency, but no oncogenic potential. Here we studied the transcriptional changes of microRNA in a series of mouse embryonic fibroblasts that have undergone transition to induced pluripotent stem cells with wild type, knock out or mutant p53 status in order to identify microRNAs whose expression during reprogramming is dependent on p53. We identified a number of microRNAs, with known functions in differentiation and carcinogenesis, the expression of which was dependent on the p53 status of the cells. Furthermore, we detected several uncharacterised microRNAs that were regulated differentially in the different p53 backgrounds, suggesting a novel role of these microRNAs in reprogramming and pluripotency.

摘要

肿瘤抑制因子p53在体细胞重编程中发挥着重要作用。野生型p53会降低重编程效率,而突变型p53则具有功能获得性活性,导致重编程效率提高。此外,表达突变型p53的诱导多能干细胞在体内会失去多能性,并在注射到小鼠体内时形成恶性肿瘤。因此,确定p53(野生型和突变型)在重编程过程中导致这种表型的靶点具有重要意义,因为这些靶点可用于治疗,即形成具有高重编程效率但无致癌潜力的诱导多能干细胞。在这里,我们研究了一系列小鼠胚胎成纤维细胞中微小RNA的转录变化,这些细胞已转变为具有野生型、敲除型或突变型p53状态的诱导多能干细胞,以便确定其在重编程过程中的表达依赖于p53的微小RNA。我们鉴定出了一些在分化和致癌过程中具有已知功能的微小RNA,其表达依赖于细胞的p53状态。此外,我们还检测到了几种在不同p53背景下差异调节的未表征微小RNA,这表明这些微小RNA在重编程和多能性方面具有新的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/3afc78952a92/cddis2016419f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/bcea81f94339/cddis2016419f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/b7a2e839dcc6/cddis2016419f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/0718a41e68eb/cddis2016419f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/3afc78952a92/cddis2016419f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/bcea81f94339/cddis2016419f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/b7a2e839dcc6/cddis2016419f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/0718a41e68eb/cddis2016419f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089a/5260988/3afc78952a92/cddis2016419f4.jpg

相似文献

1
Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells.野生型和突变型p53在诱导多能干细胞中差异调控的微小RNA
Cell Death Dis. 2016 Dec 29;7(12):e2567. doi: 10.1038/cddis.2016.419.
2
miR-34 miRNAs provide a barrier for somatic cell reprogramming.miR-34 miRNAs 为体细胞重编程提供了一道屏障。
Nat Cell Biol. 2011 Oct 23;13(11):1353-60. doi: 10.1038/ncb2366.
3
The miR-290 and miR-302 clusters are essential for reprogramming of fibroblasts to induced pluripotent stem cells.miR-290和miR-302基因簇对于将成纤维细胞重编程为诱导多能干细胞至关重要。
Stem Cells. 2025 Feb 12;43(2). doi: 10.1093/stmcls/sxae080.
4
Sirtuin 1 facilitates generation of induced pluripotent stem cells from mouse embryonic fibroblasts through the miR-34a and p53 pathways.Sirtuin 1 通过 miR-34a 和 p53 通路促进小鼠胚胎成纤维细胞生成诱导多能干细胞。
PLoS One. 2012;7(9):e45633. doi: 10.1371/journal.pone.0045633. Epub 2012 Sep 21.
5
MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling.miR-138 通过调节 p53 信号促进诱导多能干细胞生成。
Stem Cells. 2012 Aug;30(8):1645-54. doi: 10.1002/stem.1149.
6
Linking the p53 tumour suppressor pathway to somatic cell reprogramming.将p53肿瘤抑制通路与体细胞重编程联系起来。
Nature. 2009 Aug 27;460(7259):1140-4. doi: 10.1038/nature08311. Epub 2009 Aug 9.
7
Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.上皮细胞黏附分子(EpCAM)复合物蛋白促进转录因子介导的多能性重编程。
J Biol Chem. 2011 Sep 23;286(38):33520-32. doi: 10.1074/jbc.M111.256164. Epub 2011 Jul 28.
8
Long noncoding RNAs sustain high expression levels of exogenous octamer-binding protein 4 by sponging regulatory microRNAs during cellular reprogramming.长非编码 RNA 通过海绵吸附调控 microRNA 在细胞重编程过程中维持外源性 octamer-binding protein 4 的高表达水平。
J Biol Chem. 2019 Nov 22;294(47):17863-17874. doi: 10.1074/jbc.RA119.010284. Epub 2019 Oct 17.
9
Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.p53 相关通路在体细胞重编程和干细胞分化中的多重作用。
Cancer Res. 2012 Nov 1;72(21):5635-45. doi: 10.1158/0008-5472.CAN-12-1451. Epub 2012 Sep 10.
10
Histone chaperone APLF regulates induction of pluripotency in murine fibroblasts.组蛋白伴侣APLF调节小鼠成纤维细胞中多能性的诱导。
J Cell Sci. 2016 Dec 15;129(24):4576-4591. doi: 10.1242/jcs.194035. Epub 2016 Nov 14.

引用本文的文献

1
Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中p53反应性微小RNA的去调控机制及治疗机会
PeerJ. 2025 Jan 7;13:e18661. doi: 10.7717/peerj.18661. eCollection 2025.
2
MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer.由甲氧基化槲皮素糖苷调节的MALAT-1/p53/miR-155/miR-146a ceRNA回路改变了乳腺癌的免疫原性和致癌特征。
Mol Cell Biochem. 2022 Apr;477(4):1281-1293. doi: 10.1007/s11010-022-04378-4. Epub 2022 Feb 7.
3
Deficient or R273H and R248W Mutations of p53 Promote Chemoresistance to 5-FU TCF21/CD44 Axis-Mediated Enhanced Stemness in Colorectal Carcinoma.

本文引用的文献

1
Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer.肿瘤抑制性miR-218-5p通过表皮生长因子受体抑制非小细胞肺癌中的癌细胞增殖和迁移。
Oncotarget. 2016 May 10;7(19):28075-85. doi: 10.18632/oncotarget.8576.
2
P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.间质干细胞中 P53 功能异常促进骨肉瘤的发展。
Cell Death Dis. 2016 Jan 21;7(1):e2015. doi: 10.1038/cddis.2015.367.
3
Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
p53的缺陷或R273H和R248W突变促进对5-氟尿嘧啶的化疗耐药性:TCF21/CD44轴介导的结直肠癌干性增强
Front Cell Dev Biol. 2022 Jan 5;9:788331. doi: 10.3389/fcell.2021.788331. eCollection 2021.
4
Targeting mutant p53 for cancer therapy: direct and indirect strategies.针对癌症治疗的突变型 p53 靶点:直接和间接策略。
J Hematol Oncol. 2021 Sep 28;14(1):157. doi: 10.1186/s13045-021-01169-0.
5
The Function of the Mutant p53-R175H in Cancer.突变型p53-R175H在癌症中的作用
Cancers (Basel). 2021 Aug 13;13(16):4088. doi: 10.3390/cancers13164088.
6
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.抑癌基因 p53:生物学、信号通路和治疗靶点。
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188556. doi: 10.1016/j.bbcan.2021.188556. Epub 2021 Apr 29.
7
Regulation of miR-186-YY1 axis by the p53 translational isoform ∆40p53: implications in cell proliferation.p53 翻译异构体 ∆40p53 调控 miR-186-YY1 轴:对细胞增殖的影响。
Cell Cycle. 2021 Mar-Mar;20(5-6):561-574. doi: 10.1080/15384101.2021.1875670. Epub 2021 Feb 25.
8
Cancer Stemness: p53 at the Wheel.癌症干性:掌控方向盘的p53
Front Oncol. 2021 Jan 11;10:604124. doi: 10.3389/fonc.2020.604124. eCollection 2020.
9
Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer.p53 与非编码 RNA 在乳腺癌 EMT 调控中的相互作用。
Cell Death Dis. 2021 Jan 4;12(1):17. doi: 10.1038/s41419-020-03327-7.
10
The Impact of Mutant p53 in the Non-Coding RNA World.突变型 p53 在非编码 RNA 世界中的影响。
Biomolecules. 2020 Mar 19;10(3):472. doi: 10.3390/biom10030472.
抑制miR-15b可降低结直肠癌的细胞迁移和转移能力。
Tumour Biol. 2016 Jul;37(7):8765-73. doi: 10.1007/s13277-015-4396-9. Epub 2016 Jan 7.
4
miR-34a inhibits differentiation of human adipose tissue-derived stem cells by regulating cell cycle and senescence induction.微小RNA-34a通过调控细胞周期和诱导衰老来抑制人脂肪组织来源干细胞的分化。
Differentiation. 2015 Nov-Dec;90(4-5):91-100. doi: 10.1016/j.diff.2015.10.010. Epub 2015 Dec 8.
5
Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.肿瘤抑制因子p53对癌症干细胞标志物CD133的转录抑制作用。
Cell Death Dis. 2015 Nov 5;6(11):e1964. doi: 10.1038/cddis.2015.313.
6
p53 regulates the mevalonate pathway in human glioblastoma multiforme.p53调节多形性胶质母细胞瘤中的甲羟戊酸途径。
Cell Death Dis. 2015 Oct 15;6(10):e1909. doi: 10.1038/cddis.2015.279.
7
miR-15b/16-2 deletion promotes B-cell malignancies.miR-15b/16-2缺失促进B细胞恶性肿瘤。
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11636-41. doi: 10.1073/pnas.1514954112. Epub 2015 Aug 31.
8
Roles of miR-182 in sensory organ development and cancer.miR-182 在感觉器官发育和癌症中的作用。
Thorac Cancer. 2015 Jan;6(1):2-9. doi: 10.1111/1759-7714.12164. Epub 2015 Jan 7.
9
Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification.通过多重连接依赖探针扩增评估慢性淋巴细胞白血病中p53和ATM的功能
Cell Death Dis. 2015 Aug 6;6(8):e1852. doi: 10.1038/cddis.2015.223.
10
Multiple sclerosis: getting personal with induced pluripotent stem cells.多发性硬化症:借助诱导多能干细胞实现个体化治疗
Cell Death Dis. 2015 Jul 9;6(7):e1806. doi: 10.1038/cddis.2015.179.